Alexion Pharmaceuticals
Dan O'Connor is a finance professional with extensive experience in financial planning and analysis across various industries, currently serving as Senior Manager of Global Commercial FP&A at Alexion Pharmaceuticals, Inc. since January 2023. Prior roles include Financial Planning and Analysis Manager at Sovos and Senior Manager, FP&A at Fresenius Medical Care North America, where responsibilities encompassed managing expense planning, financial reporting, and creating detailed P&L statements for product lines. O'Connor's earlier career includes positions at Aspen Technology, Raytheon, and internships at Gorton's and Merrill Lynch, further enhancing proficiency in financial forecasting, reporting, and analysis. O'Connor holds a Bachelor of Business Administration in Finance from Endicott College.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.